| 商品名称 | 适用类别 | 通用名称 | 活性成分 | 产品号 | 上市许可开发者/申请人/持有人 | 上市许可日期 | 许可状态 |
|---|---|---|---|---|---|---|---|
| Sugammadex Piramal | Human | sugammadex | sugammadex sodium | EMEA/H/C/006083 | Piramal Critical Care B.V. | 2023/06/23 | Authorised |
| Sugammadex Adroiq | Human | sugammadex | sugammadex sodium | EMEA/H/C/006046 | Extrovis EU Ltd | 2023/05/26 | Authorised |
| Sugammadex Amomed | Human | sugammadex | sugammadex sodium | EMEA/H/C/005935 | AOP Orphan Pharmaceuticals GmbH | 2023/01/10 | Authorised |
| Sugammadex Fresenius Kabi | Human | sugammadex | sugammadex sodium | EMEA/H/C/005760 | Fresenius Kabi Deutschland GmbH | 2022/07/15 | Authorised |
| Sugammadex Mylan | Human | sugammadex | sugammadex sodium | EMEA/H/C/005403 | Mylan Pharmaceuticals Limited | 2021/11/15 | Authorised |
| Bridion | Human | sugammadex | sugammadex | EMEA/H/C/000885 | Merck Sharp & Dohme B.V. | 2008/07/25 | Authorised |
| Sugammadex Lorien | Human | sugammadex sodium | EMEA/H/C/006115 | LABORATORIOS LORIEN, S.L | Application withdrawn |
请输入需要查询的英文药品名称,通用名称,活性成分,产品号
药物在线相关数据库
